LI
BBIO icon

LRI Investments’s BridgeBio Pharma BBIO Stock Holding History

LRI Investments’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$968 Buy
+13
New +$911 ﹤0.01% 1383

Other funds holding BBIO

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NFT
Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LRI Investments's BBIO Position: Q2 2026 in Review

LRI Investments opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 13 shares worth $968. The stake represents ﹤0.01% of the portfolio and ranks #1383 among its holdings.

109 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • LRI Investments held 13 shares of BridgeBio Pharma worth $968 as of Q2 2026.
  • BridgeBio Pharma was a new LRI Investments position in Q2 2026.
  • BridgeBio Pharma made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1383 holding.
  • 109 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.